tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

TriSalus Life Sciences Inc

TLSI
Add to Watchlist
4.540USD
-0.020-0.44%
Close 07-31 16:00（ET）Quotes delayed by 15 min
278.83MMarket Cap
LossP/E TTM

TriSalus Life Sciences Inc

4.540
-0.020-0.44%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

TLSI Financials

See TriSalus Life Sciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

TriSalus Life Sciences Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.16
Revenue / Forecast
--/10.27M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
45.15M
53.41%
EPS(YoY)
-1.84
-40.17%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
107.68%0.03
47.50%-0.21
-693.40%-0.96
-27.42%-0.27
35.35%-0.39
74.70%-0.40
15.48%-0.12
64.67%-0.21
-71.45%-0.60
-61.99%-1.56
---0.14
---0.61
---0.35
---0.96
---0.94
----
----
----
Revenue
-2.92%8.90M
59.85%13.21M
57.38%11.57M
52.27%11.21M
41.97%9.17M
44.40%8.26M
41.52%7.35M
59.67%7.36M
116.39%6.46M
77.34%5.72M
32.34%5.19M
60.25%4.61M
25.91%2.98M
25.72%3.23M
--3.92M
--2.88M
--2.37M
--2.57M
Net Profit
113.88%1.54M
10.45%-9.75M
-1189.01%-41.27M
-75.38%-9.00M
20.92%-11.09M
70.11%-10.89M
-70.05%-3.20M
67.91%-5.13M
-51.95%-14.02M
-43.62%-36.44M
76.73%-1.88M
-84.31%-16.00M
-17.20%-9.23M
-264.47%-25.37M
---8.09M
---8.68M
---7.87M
---6.96M
Net Margin
115.28%17.29%
39.64%-73.86%
-186.34%-93.47%
-25.65%-73.91%
44.72%-113.18%
80.36%-122.36%
-18.96%-32.64%
80.58%-58.83%
26.11%-204.72%
10.85%-622.95%
---27.44%
---302.99%
---277.08%
---698.76%
---268.70%
----
----
----
Gross Margin
2.97%86.18%
1.61%86.66%
-3.26%83.52%
-4.21%83.93%
-1.50%83.69%
-5.06%85.28%
-2.62%86.34%
5.23%87.62%
9.18%84.96%
20.24%89.83%
--88.66%
--83.26%
--77.82%
--74.71%
--84.28%
----
----
----
Debt to assets ratio
-57.92%46.60%
1.52%93.53%
13.89%89.86%
19.01%78.11%
--110.74%
--92.13%
--78.90%
--65.63%
----
----
----
----
----
--1.06%
--0.06%
----
----
----
Income Statement
Revenue
-2.92%8.90M
59.85%13.21M
57.38%11.57M
52.27%11.21M
41.97%9.17M
44.40%8.26M
41.52%7.35M
59.67%7.36M
116.39%6.46M
77.34%5.72M
32.34%5.19M
60.25%4.61M
25.91%2.98M
25.72%3.23M
--3.92M
--2.88M
--2.37M
--2.57M
Operating profit
-14.76%-8.41M
56.85%-3.27M
-3.15%-9.01M
10.30%-7.33M
37.28%-7.33M
46.80%-7.58M
53.06%-8.74M
28.51%-8.17M
-15.45%-11.69M
-21.03%-14.25M
-129.52%-18.62M
-31.96%-11.43M
-28.26%-10.12M
-85.77%-11.77M
---8.11M
---8.66M
---7.89M
---6.34M
Net Profit
113.88%1.54M
10.45%-9.75M
-1189.01%-41.27M
-75.38%-9.00M
20.92%-11.09M
70.11%-10.89M
-70.05%-3.20M
67.91%-5.13M
-51.95%-14.02M
-43.62%-36.44M
76.73%-1.88M
-84.31%-16.00M
-17.20%-9.23M
-264.47%-25.37M
---8.09M
---8.68M
---7.87M
---6.96M
Balance Sheet
Current assets
171.51%68.14M
56.00%32.24M
39.99%33.33M
36.30%38.08M
90.25%25.10M
-0.93%20.67M
-18.02%23.81M
125.71%27.94M
-13.18%13.19M
21.19%20.86M
91.49%29.04M
--12.38M
--15.19M
--17.21M
--15.17M
----
----
----
Total current liabilities
0.28%11.79M
12.43%11.50M
10.00%10.91M
-22.28%9.32M
-18.35%11.75M
-30.36%10.23M
6.59%9.92M
-62.73%12.00M
-35.14%14.39M
-54.61%14.69M
-19.98%9.30M
--32.19M
--22.19M
--32.36M
--11.63M
----
----
----
Total assets
147.96%70.98M
47.39%35.33M
32.70%36.46M
27.40%41.32M
60.01%28.63M
-2.55%23.97M
-18.11%27.48M
92.92%32.43M
-9.84%17.89M
11.83%24.60M
42.21%33.55M
--16.81M
--19.84M
--22.00M
--23.59M
----
----
----
Total liabilities
-7.66%58.17M
38.76%69.19M
31.89%63.19M
7.35%60.74M
19.28%62.99M
-3.48%49.87M
91.13%47.91M
67.09%56.58M
120.44%52.81M
50.54%51.66M
85.49%25.07M
--33.86M
--23.96M
--34.32M
--13.51M
----
----
----
Total equity
137.26%12.81M
-30.77%-33.86M
-30.79%-26.73M
19.57%-19.42M
1.58%-34.37M
4.33%-25.89M
-340.77%-20.43M
-41.64%-24.15M
-748.68%-34.92M
-119.63%-27.07M
-15.81%8.49M
---17.05M
---4.12M
---12.32M
--10.08M
----
----
----
Cash Flow Statement
Net operating income
-44.03%-6.48M
56.47%-2.48M
65.81%-3.71M
45.46%-7.32M
58.60%-4.50M
37.81%-5.71M
49.93%-10.85M
-45.43%-13.42M
-3.47%-10.87M
-10.43%-9.18M
-307.41%-21.66M
-14.01%-9.23M
0.83%-10.50M
-85.24%-8.31M
---5.32M
---8.10M
---10.59M
---4.49M
Net investment
80.25%-141.00K
18.00%-41.00K
-4.14%-176.00K
255.00%93.00K
-981.82%-714.00K
86.56%-50.00K
84.80%-169.00K
-100.00%-60.00K
10.81%-66.00K
-36.76%-372.00K
-1.74%-1.11M
-36.36%-30.00K
81.45%-74.00K
50.64%-272.00K
---1.09M
---22.00K
---399.00K
---551.00K
Net financing
337.50%42.38M
-90.75%277.00K
-98.59%82.00K
-20.30%20.72M
209.92%9.69M
6862.79%2.99M
-85.53%5.82M
305.95%25.99M
-60.58%3.13M
-99.27%43.00K
908.34%40.25M
82.84%6.40M
13116.67%7.93M
43.92%5.91M
--3.99M
--3.50M
--60.00K
--4.11M

FAQs

What is the total revenue of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its total revenue reached 45.15M, with a year-on-year change of 29.43M.

What are the current assets of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its current assets were 32.24M, with a year-on-year change of 56.00.

What are the total assets of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its total assets of TriSalus Life Sciences Inc were 35.33M, with a year-on-year change of 47.39.

What are the total liabilities of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its total liabilities of TriSalus Life Sciences Inc were 69.19M, with a year-on-year change of 38.76.

What is the total equity of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its total equity of TriSalus Life Sciences Inc was -33.86M, with a year-on-year change of -30.77.

What is the net operating income of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its net operating income of TriSalus Life Sciences Inc was -26.95M, with a year-on-year change of 25.49.

What is the net investment of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its net investment of TriSalus Life Sciences Inc was -838.00K, with a year-on-year change of -142.90.

What is the net financing of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its net financing of TriSalus Life Sciences Inc was 30.76M, with a year-on-year change of -18.91.

What is the Earnings Per Share (EPS) of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.84, with a year-on-year change of -40.17.

What is the net income of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its net income was -69.69M, with a year-on-year change of -109.70.

What is the net margin of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its net profit margin was -86.88, with a year-on-year change of 14.90.

What is the gross margin of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its gross margin was 84.57, with a year-on-year change of -1.73.

What is the debt-to-asset ratio of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its debt-to-asset ratio was 93.76, with a year-on-year change of 1.33.

What is the Return on Assets (ROA) of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -132.30, with a year-on-year change of -6.93.

What is the operating profit of TriSalus Life Sciences Inc?

According to TriSalus Life Sciences Inc's FY2025 earnings report, its operating profit was -26.95M, with a year-on-year change of 25.49.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy